UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000057666 |
|---|---|
| Receipt number | R000065892 |
| Scientific Title | How to use the assessment tool to measure quality of life goal setting for improving the quality of life of cancer survivors |
| Date of disclosure of the study information | 2025/04/21 |
| Last modified on | 2025/04/21 14:13:53 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
How to use the assessment tool to measure quality of life goal setting for improving the quality of life of cancer survivors
Acronym
How to use the assessment tool to measure quality of life goal setting for improving the quality of life of cancer survivors
Scientific Title
How to use the assessment tool to measure quality of life goal setting for improving the quality of life of cancer survivors
Scientific Title:Acronym
How to use the assessment tool to measure quality of life goal setting for improving the quality of life of cancer survivors
Region
| Japan |
Condition
Condition
Cancer
Classification by specialty
| Medicine in general | Surgery in general | Rehabilitation medicine |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
This study aims to explore ways to utilize an assessment tool for measuring the quality of life goal setting (ReGAT-C) in clinical practice to improve the quality of life of cancer survivors.
Basic objectives2
Others
Basic objectives -Others
As mentioned above, ways to utilize ReGAT-C will be investigated.
Trial characteristics_1
Exploratory
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Euro Qol 5 dimensions 3-level (EQ-5D-3L): evaluate at admission and discharge
Key secondary outcomes
Reengagement Life Goal Assessment Tool for Cancer Survivors (ReGAT-C): evaluate at admission and discharge
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Treatment
Type of intervention
| Behavior,custom |
Interventions/Control_1
Physical and occupational therapists will use the ReGAT-C in their clinical practice during the hospitalization of cancer survivors. The method of using ReGAT-C will be determined based on the experience of each physical and occupational therapist.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 18 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
1. Individuals who have been informed by a physician of a cancer diagnosis
2. Individuals who are hospitalized for cancer treatment
3. Individuals aged 18 years or older
Key exclusion criteria
1. Individuals are the end-of-life stage (individuals whose prognosis for life was expected to be less than 6 months)
2. Individuals with dementia or mental illness
Target sample size
25
Research contact person
Name of lead principal investigator
| 1st name | Katsuma |
| Middle name | |
| Last name | Ikeuchi |
Organization
Prefectural University of Hiroshima
Division name
Faculty of Health and Welfare
Zip code
723-0053
Address
1-1 Gakuen-cho, Mihara-city, Hiroshima
TEL
0848-60-1175
ikeuchi@pu-hiroshima.ac.jp
Public contact
Name of contact person
| 1st name | Katsuma |
| Middle name | |
| Last name | Ikeuchi |
Organization
Prefectural University of Hiroshima
Division name
Faculty of Health and Welfare
Zip code
723-0053
Address
1-1 Gakuen-cho, Mihara-city, Hiroshima
TEL
0848-60-1175
Homepage URL
ikeuchi@pu-hiroshima.ac.jp
Sponsor or person
Institute
Prefectural University of Hiroshima
Institute
Department
Personal name
Funding Source
Organization
Japan Society for the Promotion of Science
Organization
Division
Category of Funding Organization
Japanese Governmental office
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Prefectural University of Hiroshima
Address
1-1 Gakuen-cho, Mihara-city, Hiroshima
Tel
0848-60-1175
ikeuchi@pu-hiroshima.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2025 | Year | 04 | Month | 21 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2025 | Year | 04 | Month | 17 | Day |
Date of IRB
| 2025 | Year | 01 | Month | 29 | Day |
Anticipated trial start date
| 2025 | Year | 04 | Month | 21 | Day |
Last follow-up date
| 2025 | Year | 12 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2025 | Year | 04 | Month | 21 | Day |
Last modified on
| 2025 | Year | 04 | Month | 21 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000065892
